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Introduction 
     Infectious endocarditis is an 
uncommon disease of the heart 
stemming from a bacterial or fungal 
infection on the endocardial surface of 
the heart or heart valve (Pierce, Calkins, 
& Thornton, 2012).  From review of the 
literature, infective endocarditis is fairly 
uncommon and may be difficult to 
initially diagnose.  Per Sabe, Shrestha, 
and Menon, occurrence of infective 
endocarditis (IE) is nearly 0.9-6.2 per 
100,000 persons per year (2013). 
Several preexisting conditions such as 
aging, heart valve disease, implantable 
cardiac devices, a history of heart 
disease such as rheumatic fever, and 
invasive procedures can put a patient at 
higher risk for IE (Leone et al., 2012).  
As the occurrence of IE appears to be 
rare, it is important to emphasize that 
the complications of this infection are 
abundant even when treated acutely and 
appropriately.  Per Mantan, Sethi, and 
Batra, the infection-related 
complications of IE can include 
myocardial abscess, meningitis, 
osteomyelitis, renal abscess, renal 
infarcts, glomerulonephritis, and 
purulent pericarditis (2013, p. 368).  
However, this list of complications is not 
all inclusive.  The risks of thrombolytic 
events are increased with IE and one can 
experience a stroke, pulmonary 
embolism, and even blindness (Mantan 
et al., 2013). Treatment for infectious 
endocarditis must be expediential and 
persistent.  Long term intravenous 
antibiotics are the treatment of choice 
and surgery may be indicated especially 
if a patient has a prosthetic valve 
endocarditis (Sabe et al., 2013).   
     As infective endocarditis is an 
uncommon disease, the 
pathophysiologic impact on the body is 
significant.  Proper diagnosis, 
management, and long term follow up 
could be improved through a better 
understanding of the disease process 
and systemic effects on the body.  As a 
result, a case study involving a patient 
diagnosed with Enterococcus faecalis 
infective endocarditis was chosen for 
review.  
Presentation of Case 
Signs and Symptoms 
     A 54 year old male with a prior 
medical history of hypertension, 
pyelonephritis, nephrolithiasis, and 
acute prostatitis presented to the 
emergency room in July of 2014 with 
symptoms of rigors, chills, fever,  
fraction was 55-60%.  Patient will have 
continued follow up exams with a 
cardiologist and infectious disease 
physician to monitor and screen for 
any complications related to infective 
endocarditis such as recurrent 
infection, congestive heart failure, 
valvular dysfunction, or organ 
dysfunctions. Patient was also 
instructed to report any fever greater 
than 100.0 F immediately.  Patient was 
also instructed to have antibiotic 
therapy prophylactically prior to dental 
appointments or invasive procedures. 
 
Underlying Pathophysiology 
     An infection caused by bacteria that 
enters the bloodstream and settles in 
the heart lining, valve, or blood vessel 
is endocarditis.  As bacteria is the most 
common cause of IE, viruses, fungi, and 
parasites can also cause IE (McCance, 
Huether, Brashers, & Rote, 2014).  
Blood cultures commonly isolated for 
IE are Staphylococcus aureus, viridans 
Streptococcus, and Enterococcus 
faecalis (Pierce et al., 2012).  
Enterococcus faecalis is the third most 
common cause of infective endocarditis 
and the mortality and morbidity is high 
(Miro, Pericas, & Del Rio, 2014). 
Although infective endocarditis refers 
specifically to infection in the lining of 
the heart, IE also affects the valves and 
muscles of the heart ("American Heart 
Association," 2014).   
     The pathophysiology of IE includes 
three elements of endocardial damage, 
blood-borne microorganism adherence 
to the endocardial surface that is 
damaged, and the formation of 
infective endocardial vegetations 
(McCance et al., 2014).  Endocardial 
damage can include trauma, heart 
disease, prosthetic valves and valvular 
heart disease (McCance et al., 2014).  IE 
also requires the presence of a 
microorganism in the blood and the 
attachment to the intracardiac surface 
(Pierce et al., 2012).  This can occur by 
mode of trauma, dental procedures, 
cardiac surgery, and central line 
infections.  The infective endocardial 
vegetations infiltrate the thrombi in the 
cardiac tissue and then accelerate 
fibrin formation by activating the 
clotting cascade as the bacterial 
colonies are rooted in the fibrin clots; 
making them inaccessible to host 
defenses (McCance et al., 2014).  After 
the microorganism settles on the 
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cardiac surface, the infection can 
disseminate to other tissues in the body 
causing a systemic infection ("National 




   
diplopia, and lower extremity edema 
and weakness.  Upon presentation, 
temperature was 102.0 F, pulse rate 
was 98, respirations were 24, blood 
pressure was 100/58 and oxygen 
saturation on room air was 90%.  
Pain level was 7.  Skin was 
diaphoretic and warm to touch. 
Pupils equal, round, and react to light.  
Bilateral lower extremity edema 
present with erythema.  Positive 
Homan’s sign.  Lab results revealed 
hemoglobin of 9.3. Blood cultures 
positive for Enterococcus faecalis.  CT 
scan of abdomen negative.  CT scan of 
brain negative. Chest x-ray normal.  
EKG was normal. Venous Doppler 
study negative.  Renal ultra sound 
showed stable nephrolithiasis.  Prior 
to admission, patient had been 
treated with IV antibiotics of 
Ampicillin 2 grams IV every 4 hours 
and Rocefin 1 gram every day for 2 
weeks for treatment of positive blood 
cultures of gram positive cocci.  
Patient was admitted for fever of 
unknown origin.  IV antibiotics were 
initiated. Consultations were 
performed by the infectious disease 
and cardiology teams.  A 
transthoracic echocardiogram was 
performed which revealed mitral 
valve vegetation, minimal mitral valve 
regurgitation, and a normal ejection 
fraction of 55-60%.  With positive 
blood cultures for Enterococcus 
faecalis and mitral valve vegetation 
by transthoraic echocardiogram, a 
diagnosis of Enterococcus faecalis 
endocarditis was made.  IV antibiotics 
of Ampicillin 2 grams every 4 hours 
and Gentamycin 1 gram every 8 
hours were initiated.  After blood 
pressure and fever stabilized and 
negative blood cultures were 
obtained, patient was discharged to 
home on IV Ampicillin 2 grams every 
4 hours and IV Gentamycin 1 gram 
every 8 hours via PICC line for 4 
weeks.  After completion of antibiotic 
therapy, patient had follow up with 
infectious disease physician and 
cardiologist.  A repeat transthoracic 
echocardiogram was completed 
which showed anterior mitral valve 
leaflet thickening with no 
enlargement of the echo density seen 
on prior exam and borderline 
concentric left ventricular 
hypertrophy with mass not 
prolapsing into left atrium. Ejection 
Figure 1: Infectious Endocarditis of 
Mitral Valve (Cabell, Abrutyn, & 
Karchmer, 2003, figure 1). 
 
Significance of Pathophysiology 
     Infective endocarditis is 
uncommon, but the effects from the 
disease process can involve several 
organ systems including cardiac, 
neurological, musculoskeletal and 
renal systems and can be fatal if not 
treated in an expedited fashion. 
Infection related complications of IE 
can include embolism, heart valve 
destruction and heart failure, 
osteomyelitis, pericarditis, 
glomerulonephritis, and blindness 
(Mantan et al., 2013).  Embolic risk 
occurs in 22%-50% of patients with 
IE and involve complication of 
stroke and pulmonary embolism 
(Anavekar et al., 2011). Emboli 
from IE can often involve the lungs, 
coronary arteries, spleen, GI system, 
extremities, and central nervous 
system (Chung, Chen, Tai, Huang, & 
Chen, 2014). Embolic events related 
to IE can cause devastating 
neurologic damage and organ 
failure (Sabe et al., 2013).  Cardiac 
complications are serious and 
include formations of heart 
murmurs, heart valve regurgitation, 
and congestive heart failure 
(Mocchegian & Nataloni, 2009).  
Additional complications include 
damage to the conduction system of 
the heart leading to bundle branch 
block, intra-cardiac fistulas, and 
pericarditis (Sabe et al., 2013).  
Heart valve replacement may need 
to be a consideration if patient has 
extensive damage to a heart valve.   
      
Renal complications of IE occurs in 
approximately 25% of the patients 
and the most common diagnosis are 
renal infarcts, renal abscesses, 
glomerulonephritis and interstitial 
nephritis (Mantan et al., 2013). 
Implications for 
Nursing Care 
     The clinical manifestations and 
multi-organ involvement of IE are 
many.  Diagnosis of IE is based on 
clinical, microbiologic, and 
echocardiographic findings (Chung et 
al., 2014).  Evaluation and work up 
for diagnosis of IE should include 
cardiac assessment for heart murmur 
or heart failure which would include 
a baseline electrocardiogram, an 
echocardiogram, blood cultures prior 
to initiation of antibiotic therapy, 
evaluation for petechiae of mucous 
membranes and extremities, 
complete blood count, serum 
electrolytes, and urinalysis for 
hematuria, proteinuria, or pyuria 
(Pierce et al., 2012). The principles of 
therapy for IE is initial hemodynamic 
stabilization, obtaining blood cultures 
for microbial identification and 
treatment (Sabe et al., 2013). 
Echocardiography is also one 
diagnostic modality in patients with 
suspected IE. Evaluation of IE has 
improved dramatically after the 
introduction of echocardiography 
which is the primary technique for 
the detection of vegetations on the 
heart wall and valves and IE related 
complications (Cecchi et al., 2013).  
Clinical judgment is crucial in the first 
stages of care for a patient with IE.  
Systematic evaluation and 
assessment is essential and nurses 
evaluating patients can be advocates 
in the initiation of appropriate tests 
and evaluations.  Although 
uncommon, knowing predictive 
factors for IE is useful in identifying 
patients with IE.  These factors 
include: being male, prior valvular 
heart damage, fever, stroke, emboli, 
splenomegaly, leukocytosis, and 
thrombocytopenia (Chung et al., 
2014).  The latest American Heart 
Association guidelines recommend 
penicillin or ampicillin plus 
gentamicin for 4 to 6 weeks as the 
combination of choice for 
Enterococcus faecalis infective 
endocarditis (Miro et al., 2014).  It is 
also imperative to have an infectious 
disease consultation for the patient 
in addition to a cardiology consult.  
ID consultation has been associated 
with improved outcomes including 
improved survival (Yamamoto et al., 
2012).  Follow up and patient 
education is important.  Intravenous 
catheters should be removed 
immediately following completion of 
antibiotic therapy and transthoracic 
echocardiography should be 
performed to establish a new 
baseline result for the patient 
(Pierce et al., 2012).  Patients should 
also receive education regarding the 
importance of regular follow up 
visits to their specialists including 
infectious disease and cardiology. 
(Pierce et al., 2012).  In addition, 
patients need to know that they may 
require antibiotic therapy prior to 
invasive procedures.  The American 
Heart Association recommends 
antibiotic prophylaxis prior to dental 
procedure for patients with a history 





      
Figure 2: Infectious Endocarditis of 
Mitral Valve (American Heart 
Association website, 2008). 
Conclusions 
     Infective endocarditis occurs at a 
low rate, but can be associated with 
high morbidity and mortality, with 
mortality occurring at a rate of 15-
40%, in light of antibiotic and 
surgical advancements (Sabe et al., 
2013).  Early diagnosis of IE is 
crucial for successful clinical 
outcomes and prevention of long 
term complications.  Treatment of IE 
should be targeted toward the 
causative microorganism, based on 
the cardiac valve involved, and the 
clinical status of the patient (Sabe et 
al., 2013).  
A multimodality approach in care 
and treatment is essential and 
should include a collaborative effort 
between the infectious disease 
specialist, primary care physician, 
cardiologist, cardiothoracic 
surgeons, and nursing team.    
Through enhanced awareness of IE, 
improved outcomes from this 
disease can be realized.  
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